Stillidsvej 2 ApS: Financial statements 2022
CVR: 39012448
Stillidsvej 2 ApS (CVR 39012448) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -6,250 and a net result of DKK -4,893 compared with DKK -4,087 the year before. Equity amounted to DKK 21,716. The solvency ratio was 43.4%.
- Gross Profit
- -6,250 kr.
- Profit/Loss
- -4,893 kr.
- Equity
- 21,716 kr.
- Total Assets
- 50,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -6 t. | -5 t. | 22 t. | - |
| 2021 | - | -6 t. | -4 t. | 27 t. | - |
| 2020 | - | -4 t. | -7 t. | 31 t. | - |
| 2019 | - | 0 | 4 t. | 37 t. | - |
Keep an eye on Stillidsvej 2 ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Stillidsvej 2 ApS has published its annual report for 2021. Gross profit came to DKK -6,250, and the net result was DKK -4,087.
About Stillidsvej 2 ApS
Stillidsvej 2 ApS is a Danish company of the type Anpartsselskab based in Skødstrup, founded in 2017. The company is registered under the industry Detailhandel med andre fødevarer. The company was previously named CBD Pharma ApS. The management consists of Lars Folkmann and Dan Ringsted Jacobsen. The company is owned by HPD Group ApS. In 2025, the company reported a gross profit of DKK -6,250 and a net result of DKK -6,350 compared with DKK -3,647 the year before. Equity amounted to DKK 105,137.
